GNPX: Genprex, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.10
Enterprise Value ($M) 2.61
Book Value ($M) 1.66
Book Value / Share 0.46
Price / Book 2.46
NCAV ($M) -0.32
NCAV / Share -0.09
Price / NCAV -12.63

Profitability (mra)
Return on Invested Capital (ROIC) -13.64
Return on Assets (ROA) -1.36
Return on Equity (ROE) -1.85

Liquidity (mrq)
Quick Ratio 0.86
Current Ratio 0.86

Balance Sheet (mrq) ($M)
Current Assets 1.92
Assets 3.91
Liabilities 2.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-24 13G/A Otsuka Masaya 0.00 -100.00
10-03 13G Forsakringsaktiebolaget Avanza Pension 5.00
02-14 13G/A CVI Investments, Inc. 4.90 -10.86

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 166,713 514,923 32.38
2024-11-21 247,734 714,468 34.67
2024-11-20 302,625 922,143 32.82
2024-11-19 145,491 408,761 35.59

(click for more detail)

Similar Companies
GLSI – Greenwich LifeSciences, Inc. GLTO – Galecto, Inc.
GNLX – Genelux Corporation GOVX – GeoVax Labs, Inc.
GRCE – Grace Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.